Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma. (31st December 2023)

• Record Type: Journal Article
• Authors: Burkett, Wesley C.; Zhao, Ziyi; Newton, Meredith A.; Sun, Wenchuan; Deng, Boer; Secord, Angeles Alvarez; Zhou, Chunxiao; Bae-Jump, Victoria
• Is Part Of: Annals of medicine. Volume 55:Number 1(2023)
• Page Start: 603
• Page End: 614
• Publication Date: 2023-12-31
• Subjects: Ipatasertib -- apoptosis -- invasion -- synergy -- carboplatin -- uterine serous carcinoma; Medicine -- Periodicals; 610
• DOI: 10.1080/07853890.2023.2177883
• Languages: English
• ISSNs: 0785-3890

Abstract

Abstract: Purpose: Uterine serous carcinoma (USC) exhibits worse survival rates compared to the endometrioid subtype, and there is currently no effective treatment options for recurrence of this disease after platinum-based chemotherapy. Activation of PIK3CA/AKT/mTOR signaling pathway is a common biological feature in USC. Materials and Methods: Ipatasertib (IPAT) is an investigational, orally administered, ATP-competitive, highly selective inhibitor of pan AKT that has demonstrated anti-proliferative activity in a variety of tumor cells and tumor models. In this study, we used IPAT, carboplatin and their combination to investigate the anti-tumor activity in SPEC-2 and ARK-1 cells. Results: Our results indicate that IPAT combined with carboplatin at low doses was more effective at reducing proliferation, inducing apoptosis and causing cellular stress than IPAT or carboplatin alone. In particular, inhibition of the PIK3CA/AKT/mTOR pathway and induction of DNA damage were involved in the synergistic inhibition by combination treatment of cell viability in USC cells treated with the combination. Furthermore, IPAT in combination with carboplatin significantly reduced cell adhesion and inhibited cell invasion. Conclusions: These findings suggest that the combination of IPAT and carboplatin has potential clinical implications for developing new USC treatment strategies.